全文获取类型
收费全文 | 1962篇 |
免费 | 110篇 |
国内免费 | 32篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 36篇 |
妇产科学 | 16篇 |
基础医学 | 220篇 |
口腔科学 | 29篇 |
临床医学 | 129篇 |
内科学 | 602篇 |
皮肤病学 | 21篇 |
神经病学 | 146篇 |
特种医学 | 43篇 |
外科学 | 329篇 |
综合类 | 13篇 |
预防医学 | 84篇 |
眼科学 | 56篇 |
药学 | 125篇 |
中国医学 | 8篇 |
肿瘤学 | 223篇 |
出版年
2023年 | 16篇 |
2022年 | 46篇 |
2021年 | 58篇 |
2020年 | 41篇 |
2019年 | 49篇 |
2018年 | 58篇 |
2017年 | 46篇 |
2016年 | 74篇 |
2015年 | 58篇 |
2014年 | 90篇 |
2013年 | 102篇 |
2012年 | 145篇 |
2011年 | 160篇 |
2010年 | 79篇 |
2009年 | 68篇 |
2008年 | 108篇 |
2007年 | 111篇 |
2006年 | 92篇 |
2005年 | 92篇 |
2004年 | 107篇 |
2003年 | 97篇 |
2002年 | 107篇 |
2001年 | 31篇 |
2000年 | 32篇 |
1999年 | 40篇 |
1998年 | 31篇 |
1997年 | 16篇 |
1996年 | 22篇 |
1995年 | 15篇 |
1994年 | 18篇 |
1993年 | 7篇 |
1992年 | 10篇 |
1991年 | 13篇 |
1990年 | 7篇 |
1989年 | 8篇 |
1988年 | 8篇 |
1987年 | 8篇 |
1986年 | 6篇 |
1985年 | 3篇 |
1983年 | 5篇 |
1981年 | 4篇 |
1978年 | 2篇 |
1971年 | 1篇 |
1969年 | 2篇 |
1968年 | 2篇 |
1967年 | 1篇 |
1966年 | 1篇 |
1965年 | 1篇 |
1962年 | 1篇 |
1956年 | 1篇 |
排序方式: 共有2104条查询结果,搜索用时 15 毫秒
81.
Elevated Fibroblast Growth Factor 23 Exerts Its Effects on Placenta and Regulates Vitamin D Metabolism in Pregnancy of Hyp Mice 下载免费PDF全文
Yasuhisa Ohata Miwa Yamazaki Masanobu Kawai Naoko Tsugawa Kanako Tachikawa Tomoko Koinuma Kazuaki Miyagawa Akihito Kimoto Masahiro Nakayama Noriyuki Namba Hironori Yamamoto Toshio Okano Keiichi Ozono Toshimi Michigami 《Journal of bone and mineral research》2014,29(7):1627-1638
Fibroblast growth factor 23 (FGF23) functions in an endocrine fashion and requires α‐Klotho to exert its effects on the target organs. We have recently demonstrated that the human placenta also expresses α‐Klotho, which led us to hypothesize that FGF23 may exert effects on the placenta. Immunohistochemical analysis demonstrated the expression of FGF receptor 1 (FGFR1) as well as that of α‐Klotho in the feto‐maternal interface of both mouse and human normal‐term placentas, which suggested that these areas might be receptive to FGF23. Therefore, we next investigated whether FGF23 has some roles in the placenta using Hyp mice with high levels of circulating FGF23. Hyp and wild‐type (WT) females were mated with WT males, and the mothers and their male fetuses were analyzed. FGF23 levels in Hyp mothers were elevated. FGF23 levels were about 20‐fold higher in Hyp fetuses than in Hyp mothers, whereas WT fetuses from Hyp mothers exhibited low levels of FGF23, as did fetuses from WT mothers. We analyzed the placental gene expression and found that the expression of Cyp24a1 encoding 25OHD‐24‐hydroxylase, a target gene for FGF23 in the kidney, was increased in the placentas of fetuses from Hyp mothers compared with fetuses from WT mothers. In an organ culture of WT placentas, treatment with plasma from Hyp mothers markedly increased the expression of Cyp24a1, which was abolished by the simultaneous addition of anti‐FGF23 neutralizing antibody. The direct injection of recombinant FGF23 into WT placentas induced the expression of Cyp24a1. The increase in the placental expression of Cyp24a1 in fetuses from Hyp mothers resulted in decreased plasma 25‐hydroxyvitamin D levels. These results suggest that increased levels of circulating FGF23 in pathological conditions such as Hyp mice exerts direct effects on the placenta and affects fetal vitamin D metabolism via the regulation of Cyp24a1 expression. © 2014 American Society for Bone and Mineral Research. 相似文献
82.
83.
Akitoshi Hakoda Toshihisa Takeuchi Yuichi Kojima Yasuhiro Fujiwara Yasuaki Nagami Yuji Naito Shinsaku Fukuda Tomoyuki Koike Mitsushige Sugimoto Kenta Hamada Hideki Kobara Norimasa Yoshida Tomoki Inaba Akihito Nagahara Eriko Koizumi Kazunari Murakami Takahisa Furuta Naotaka Ogasawara Hajime Isomoto Kotaro Shibagaki Hiromi Kataoka Hidekazu Suzuki Kazuhide Higuchi 《Journal of Clinical Biochemistry and Nutrition》2022,70(2):189
Bleeding after gastric endoscopic submucosal dissection (ESD) remains problematic, especially in patients receiving antithrombotic therapy. Therefore, this study aimed to identify the risk factors. In this retrospective study, patients (n = 1,207) who underwent gastric ESD while receiving antithrombotic therapy were enrolled at Osaka Medical and Pharmaceutical University Hospital and 18 other referral hospitals in Japan. Risks of post-ESD bleeding were calculated using multivariable logistic regression. The dataset was divided into a derivation cohort and a validation cohort. We created a prediction model using the derivation cohort. The accuracy of the model was evaluated using the validation cohort. Post-ESD bleeding occurred in 142 (11.8%) participants. Multivariable analysis yielded an odds ratio of 2.33 for aspirin, 4.90 for P2Y12 receptor antagonist, 1.79 for cilostazol, 0.95 for other antithrombotic agents, 6.53 for warfarin, 5.65 for dabigatran, 7.84 for apixaban, 10.45 for edoxaban, 6.02 for rivaroxaban, and 1.46 for heparin bridging. The created prediction model was called safe ESD management using the risk analysis of post-bleeding in patients with antithrombotic therapy (SAMURAI). This model had good predictability, with a C-statistic of 0.77. In conclusion, use of the SAMURAI model will allow proactive management of post-ESD bleeding risk in patients receiving antithrombotic therapy. 相似文献
84.
BACKGROUND Cognitive decline is common among older patients with cardiovascular disease(CVD) and can decrease their self-management abilities. However, the instruments for identifying mild cognitive impairment(MCI) are not always feasible in clinical practice. Therefore, this study evaluated whether MCI could be detected using the Japanese version of the Rapid Dementia Screening Test(RDST-J), which is a simple screening tool for identifying cognitive decline.METHODS This retrospective single-center study included patients who were ≥ 65 years old and hospitalized because of CVD.Patients with a pre-hospitalization diagnosis of dementia were excluded. Each patient's cognitive function had been measured at discharge using the RDST-J and the Japanese version of the Montreal Cognitive Assessment(Mo CA-J), which is a standard tool for MCI screening. The correlation between the two scores was evaluated using Spearman's rank correlation coefficient. Receiver operating characteristic(ROC) analysis was also to evaluate whether the RDST-J could identify MCI, which was defined as a Mo CA-J score of ≤ 25 points.RESULTS The study included 78 patients(mean age: 77.2 ± 8.9 years). The RDST-J and Mo CA-J scores were strongly correlated(r = 0.835, P < 0.001). The ROC analysis revealed that an RDST-J score of ≤ 9 points provided 75.4% sensitivity and 95.2% specificity for identifying MCI, with an area under the curve of 0.899(95% CI: 0.835-0.964). The same cut-off value was identified when excluding patients with a high probability of dementia(RDST-J score of ≤ 4 points).CONCLUSIONS The RDST-J may be a simple and effective tool for identifying MCI in older patients with CVD. 相似文献
85.
Eri Koshi‐Ito Kiyomi Koike Akihito Tanaka Yu Watanabe Naoki Kamegai Hiroya Shimogushi Hibiki Shinjo Yasuhiro Otsuka Daijo Inaguma Asami Takeda 《Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy》2019,23(6):575-583
Low‐density lipoprotein apheresis (LDL‐A) has been used for nephrotic syndrome (NS) caused by focal segmental glomerulosclerosis in Japan. Idiopathic membranous nephropathy (iMN) can also cause treatment‐resistant NS. Therefore, we investigated the effect of LDL‐A during initial induction for it. This retrospective, observational, and single‐center study enrolled consecutive iMN patients who received steroids from March 2000 to May 2015. We compared data between 11 patients treated with LDL‐A (LDL‐A group) and 27 patients without (non‐LDL‐A group) at baseline and 4 and 8 weeks later. Reduction rate of proteinuria and increase rate of serum albumin in LDL‐A group were significantly higher than the other after 4 weeks (P = 0.036 and 0.030) and 8 weeks (P = 0.030 and <0.001), respectively. There was no adverse event caused by LDL‐A and immunosuppressant dose was not significantly different. In conclusion, LDL‐A may be an effective choice for initial induction of nephrotic iMN. 相似文献
86.
Kentaro Ukita Kanako Otomune Ryo Fujimoto Kanako Hasegawa Koichi Izumikawa Nobutoshi Morimoto Kazuhiro Sasaki Akihito Hirasaki Koichi Takaguchi 《Clinical Case Reports》2022,10(1)
Causative agent identification is important in the treatment of poisoning. We report the case of a patient who presented with an altered level of consciousness after drinking a fluorescent pink liquid. Upon measuring the anion gap and urinary calcium oxalate level, the patient was diagnosed with early ethylene glycol poisoning. 相似文献
87.
88.
Yoshida Akihito Motomura Kazuya Natsume Atsushi Chalise Lushun Iijima Kentaro Hara Daisuke Kadono Izumi Wakai Kenji Wakabayashi Toshihiko 《Journal of neuro-oncology》2020,146(1):195-205
Journal of Neuro-Oncology - This study aimed to investigate the preoperative predictive factors affecting return to work in patients with gliomas in the left cerebral hemisphere undergoing awake... 相似文献
89.
Yasufumi Masaki Hiroshi Kawabata Kazue Takai Masaru Kojima Norifumi Tsukamoto Yasuhito Ishigaki Nozomu Kurose Makoto Ide Jun Murakami Kenji Nara Hiroshi Yamamoto Yoko Ozawa Hidekazu Takahashi Katsuhiro Miura Tsutomu Miyauchi Shinichirou Yoshida Akihito Momoi Nobuyasu Awano Soichiro Ikushima Yasunori Ohta Natsue Furuta Shino Fujimoto Haruka Kawanami Tomoyuki Sakai Takafumi Kawanami Yoshimasa Fujita Toshihiro Fukushima Shigeo Nakamura Tomohiro Kinoshita Sadao Aoki 《International journal of hematology》2016,103(6):686-692
90.
Ayato Murata Takuya Genda Takafumi Ichida Nozomi Amano Sho Sato Hironori Tsuzura Shunsuke Sato Yutaka Narita Yoshio Kanemitsu Yuji Shimada Katsuharu Hirano Katsuyori Iijima Ryo Wada Akihito Nagahara Sumio Watanabe 《World journal of gastroenterology : WJG》2016,22(33):7569-7578
AIM To clarify the association between aldo-keto reductase family 1 member B10(AKR1B10) expression and hepatocarcinogenesis after hepatitis C virus eradication.METHODS In this study,we enrolled 303 chronic hepatitis C patients who had achieved sustained virological response(SVR) through interferon-based antiviral therapy. Pretreatment AKR1B10 expression in the liver was immunohistochemically assessed and quantified as a percentage of positive staining area by using image-analysis software. A multivariate Cox analysis was used to estimate the hazard ratios(HRs) of AKR1B10 expression for hepatocellular carcinoma(HCC) development after achieving SVR. The cumulative incidences of HCC development were evaluated using Kaplan-Meier analysis and the log-rank test.RESULTS Of the 303 chronic hepatitis C patients,153(50.5%) showed scarce hepatic AKR1B10 expression,quantified as 0%,which was similar to the expression in control normal liver tissues. However,the remaining 150 patients(49.5%) exhibited various degrees of AKR1B10 expression in the liver,with a maximal AKR1B10 expression of 73%. During the median follow-up time of 3.6 years(range 1.0-10.0 years),8/303 patients developed HCC. Multivariate analysis revealed that only high AKR1B10 expression(≥ 8%) was an independent risk factor for HCC development(HR = 15.4,95%CI: 1. 8- 1 3 2. 5,P = 0. 0 1 2). T h e 5- y e a r c u m u l a t i v e incidences of HCC development were 13.7% and 0.5% in patients with high and low AKR1B10 expression,respectively(P 0.001). During the follow-up period after viral eradication,patients expressing high levels of AKR1B10 expressed markedly higher levels of alanine aminotransferase and α-fetoprotein than did patients exhibiting low AKR1B10 expression.CONCLUSION Chronic hepatitis C patients expressing high levels of hepatic AKR1B10 had an increased risk of HCC development even after SVR. 相似文献